| CYHS2400818 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2024-03-13 | | Fresenius Kabi (Wuhan) Pharmaceutical Co Ltd | | | view |
| CXL01213 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(5) | New Drug Application | 2001-05-11 | 安万特（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Approval | | view |
| CYHB2200116 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Supplementary Application | 2022-01-14 | | | | | view |
| JYHB2300667 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-11-21 | | | | | view |
| CYHS2400819 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2024-03-13 | | Fresenius Kabi (Wuhan) Pharmaceutical Co Ltd | | | view |
| CYHB2201429 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2022-08-12 | | Qilu Pharmaceutical (Hainan) Co Ltd | | | view |
| JYHB2300060 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-01-20 | | | | | view |
| JYHB2300741 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-12-22 | | | | | view |
| CYHS2101545 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2021-08-10 | | Furen Hetero Onco Therapeutics Ltd | | | view |
| JYHB2300061 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-01-20 | | | | | view |
| JYHB2300742 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-12-22 | | | | | view |
| CYHS2101544 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2021-08-10 | | Furen Hetero Onco Therapeutics Ltd | | | view |
| CYHS2401719 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2024-06-07 | | | | | view |
| H20020127 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Import Drug Application | 2002-05-30 | 安万特（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| JYHB2300059 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-01-20 | | | | | view |
| JYHB2300668 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2023-11-21 | | | | | view |
| CYHB2201430 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2022-08-12 | | Qilu Pharmaceutical (Hainan) Co Ltd | | | view |
| CYHS2401718 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Generic Drug | 2024-06-07 | | | | | view |
| CXL01212 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(5) | New Drug Application | 2001-05-11 | 安万特（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | | | view |
| CYHB2201783 | 盐酸伊立替康注射液 | irinotecan hydrochloride | Injection | Chemical Drugs(4) | Supplementary Application | 2022-09-29 | | Sichuan Huiyu Pharmaceutical Co Ltd | | | view |
